ADA adjuvants

Adjuvants are vital ingredients used in vaccinology for enhancing the strength and duration of immune protection. AdJane has developed its own adjuvants, ADA-24 for intramuscular administration and ADA-25 for intranasal administration, based on its proprietary OMV-Vacc platform technology. Unlike traditional adjuvants, ADA elicits both cellular (Th1), humoral (Th2), and mucosal (Th17) immune responses, resulting in stronger, more durable immunity. Our proprietary adjuvants are highly versatile and can be incorporated into bacterial or viral concepts, and produced in short timelines at high quality, following GMP requirements. 

ADA-25 has shown an excellent safety profile in a Phase 1 clinical trial.